artificial intelligence

By Dave Muoio May 15, 2019
Aidoc, an Israeli provider of artificial intelligence products for radiologists, announced today that it has received FDA clearance for a tool that identifies potential cases of pulmonary embolism — a blockage in one of the lung’s pulmonary arteries — for expert review. “We chose to focus on this product because these are patients who might not necessarily have clear symptoms of pulmonary...
By Dave Muoio May 8, 2019
Google goes big on AI for accessibility. A substantial portion of yesterday’s Google I/O developer conference keynote was devoted to the tech giant’s efforts on increasing device accessibility for those with speech, vision and hearing impairments. During its onstage presentation, the company demonstrated how artificial intelligence could record, interpret and ultimately transcribe the speech of...
dementia
By Piers Ford April 25, 2019
Summary The UK Dementia Research Institute has appointed its seventh research centre – a £20 million facility based at Imperial College London, which will be tasked with developing new technologies to help people live in ‘dementia-friendly’ homes, as well as gathering insights into how the condition develops. With the collaboration of the University of Surrey, the new centre will bring together...
By Dave Muoio April 18, 2019
Yesterday PathAI, a Boston-based maker of artificial intelligence tools for pathology, closed a $60 million Series B funding round led by General Atlantic. Other existing investors, most notably General Catalyst, also participated in the round. To monitor its investment, General Atlantic Managing Director Dr. Michelle Dipp will also be joining the AI company’s board of directors. WHAT THEY DO...
By Laura Lovett April 9, 2019
The stakes are high when it comes to implementing artificial intelligence in healthcare, Massachusetts Governor Charlie Baker reminded the audience at the World Medical Innovation Forum in Boston yesterday.  While the technology has the ability to shape the future of health, Baker — who previously served as the CEO of Harvard Pilgrim Health Care — urged the industry to be mindful about data...
By Dave Muoio April 8, 2019
Deep Lens, a digital pathology startup particularly focused on cancer trials, has brought in a $13.65 million Series A round, according to an SEC filing. The fundraise was headed by Northpond Ventures with additional support from prior investors Rev1 Ventures, Sierra Ventures and Tamarind-Hill Partners, according to a release. The Series A comes quickly after a seed funding round that raised just...

Credit: Landing Medical

By Dean Koh April 5, 2019
China Maternal and Child Health Care Association and Wuhan University Landing AI Cytology Diagnostic Centre recently launched a cervical cancer screening AI cloud diagnostic platform. The platform can be accessed worldwide as of April 1, 2019 and women, especially those from countries along Belt and Road Initiative, will be able to benefit from a high-quality, low-cost cervical cancer screening...
By Jonah Comstock April 3, 2019
FDA Commissioner Dr. Scott Gottlieb may be stepping down, but he isn’t slowing down on his way out the door. Yesterday the agency dropped a 20-page exploratory whitepaper on how it could address artificial intelligence and machine learning algorithms. “As algorithms evolve, the FDA must also modernize our approach to regulating these products,” Gottlieb wrote in a statement. “We must ensure that...

Joseph Mossel, CEO & co-founder of Ibex Medical Analytics, speaking at the recently held MEDinISRAEL event. Credit: Ibex Medical Analytics

By Dean Koh March 27, 2019
Ibex Medical Analytics, an Israel-based startup founded in 2016 which is developing their own AI-driven computational pathology cancer diagnosis system, recently completed an $11M Series A funding round led by aMoon Fund. Additional investors in the round include Kamet Ventures, an investment arm of AXA Insurance, one of the largest global health insurance providers, 83North, a global venture...

Photo credit: Nvidia

By Laura Lovett March 20, 2019
As more big names in tech are jumping into the healthcare arena, the industry is getting a makeover. Now Nvidia, a hardware company best known for creating consumer and professional-grade graphics processing units (GPUs) as well as chip units for mobile computing, sees an opportunity to carve out a bigger name for itself in the space. “I think that computational biology is the future,” Kimberly...
buy steroids canada